256 related articles for article (PubMed ID: 12663261)
1. Control of cardiac pyruvate dehydrogenase activity in peroxisome proliferator-activated receptor-alpha transgenic mice.
Hopkins TA; Sugden MC; Holness MJ; Kozak R; Dyck JR; Lopaschuk GD
Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H270-6. PubMed ID: 12663261
[TBL] [Abstract][Full Text] [Related]
2. Selective modification of pyruvate dehydrogenase kinase isoform expression in rat pancreatic islets elicited by starvation and activation of peroxisome proliferator-activated receptor-alpha: implications for glucose-stimulated insulin secretion.
Sugden MC; Bulmer K; Augustine D; Holness MJ
Diabetes; 2001 Dec; 50(12):2729-36. PubMed ID: 11723055
[TBL] [Abstract][Full Text] [Related]
3. PPAR alpha ligand protects during cisplatin-induced acute renal failure by preventing inhibition of renal FAO and PDC activity.
Li S; Wu P; Yarlagadda P; Vadjunec NM; Proia AD; Harris RA; Portilla D
Am J Physiol Renal Physiol; 2004 Mar; 286(3):F572-80. PubMed ID: 14612380
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of the mammalian pyruvate dehydrogenase kinases in the prevention of hyperglycaemia.
Sugden MC; Holness MJ
Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):151-65. PubMed ID: 12476789
[TBL] [Abstract][Full Text] [Related]
5. Role of peroxisome proliferator-activated receptor-alpha in the mechanism underlying changes in renal pyruvate dehydrogenase kinase isoform 4 protein expression in starvation and after refeeding.
Sugden MC; Bulmer K; Gibbons GF; Holness MJ
Arch Biochem Biophys; 2001 Nov; 395(2):246-52. PubMed ID: 11697863
[TBL] [Abstract][Full Text] [Related]
6. Chronic inhibition of pyruvate dehydrogenase in heart triggers an adaptive metabolic response.
Chambers KT; Leone TC; Sambandam N; Kovacs A; Wagg CS; Lopaschuk GD; Finck BN; Kelly DP
J Biol Chem; 2011 Apr; 286(13):11155-62. PubMed ID: 21321124
[TBL] [Abstract][Full Text] [Related]
7. Selective modification of the pyruvate dehydrogenase kinase isoform profile in skeletal muscle in hyperthyroidism: implications for the regulatory impact of glucose on fatty acid oxidation.
Sugden MC; Lall HS; Harris RA; Holness MJ
J Endocrinol; 2000 Nov; 167(2):339-45. PubMed ID: 11054649
[TBL] [Abstract][Full Text] [Related]
8. Pyruvate dehydrogenase activation and kinase expression in human skeletal muscle during fasting.
Spriet LL; Tunstall RJ; Watt MJ; Mehan KA; Hargreaves M; Cameron-Smith D
J Appl Physiol (1985); 2004 Jun; 96(6):2082-7. PubMed ID: 14966024
[TBL] [Abstract][Full Text] [Related]
9. Activation of PPAR-α in the early stage of heart failure maintained myocardial function and energetics in pressure-overload heart failure.
Kaimoto S; Hoshino A; Ariyoshi M; Okawa Y; Tateishi S; Ono K; Uchihashi M; Fukai K; Iwai-Kanai E; Matoba S
Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H305-H313. PubMed ID: 28011586
[TBL] [Abstract][Full Text] [Related]
10. A novel inhibitor of pyruvate dehydrogenase kinase stimulates myocardial carbohydrate oxidation in diet-induced obesity.
Wu CY; Satapati S; Gui W; Wynn RM; Sharma G; Lou M; Qi X; Burgess SC; Malloy C; Khemtong C; Sherry AD; Chuang DT; Merritt ME
J Biol Chem; 2018 Jun; 293(25):9604-9613. PubMed ID: 29739849
[TBL] [Abstract][Full Text] [Related]
11. A role for peroxisome proliferator-activated receptor alpha (PPARalpha ) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase.
Campbell FM; Kozak R; Wagner A; Altarejos JY; Dyck JR; Belke DD; Severson DL; Kelly DP; Lopaschuk GD
J Biol Chem; 2002 Feb; 277(6):4098-103. PubMed ID: 11734553
[TBL] [Abstract][Full Text] [Related]
12. Investigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormone.
Holness MJ; Bulmer K; Smith ND; Sugden MC
Biochem J; 2003 Feb; 369(Pt 3):687-95. PubMed ID: 12435272
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the role of peroxisome-proliferator-activated receptor alpha in the regulation of cardiac pyruvate dehydrogenase kinase 4 protein expression in response to starvation, high-fat feeding and hyperthyroidism.
Holness MJ; Smith ND; Bulmer K; Hopkins T; Gibbons GF; Sugden MC
Biochem J; 2002 Jun; 364(Pt 3):687-94. PubMed ID: 12049632
[TBL] [Abstract][Full Text] [Related]
14. Chronic activation of PPARalpha is detrimental to cardiac recovery after ischemia.
Sambandam N; Morabito D; Wagg C; Finck BN; Kelly DP; Lopaschuk GD
Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H87-95. PubMed ID: 16155108
[TBL] [Abstract][Full Text] [Related]
15. Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-alpha ligands, glucocorticoids, and insulin.
Huang B; Wu P; Bowker-Kinley MM; Harris RA
Diabetes; 2002 Feb; 51(2):276-83. PubMed ID: 11812733
[TBL] [Abstract][Full Text] [Related]
16. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta.
Muoio DM; MacLean PS; Lang DB; Li S; Houmard JA; Way JM; Winegar DA; Corton JC; Dohm GL; Kraus WE
J Biol Chem; 2002 Jul; 277(29):26089-97. PubMed ID: 12118038
[TBL] [Abstract][Full Text] [Related]
17. Role of pyruvate dehydrogenase kinase isoenzyme 4 (PDHK4) in glucose homoeostasis during starvation.
Jeoung NH; Wu P; Joshi MA; Jaskiewicz J; Bock CB; Depaoli-Roach AA; Harris RA
Biochem J; 2006 Aug; 397(3):417-25. PubMed ID: 16606348
[TBL] [Abstract][Full Text] [Related]
18. Estrogen-related receptors stimulate pyruvate dehydrogenase kinase isoform 4 gene expression.
Zhang Y; Ma K; Sadana P; Chowdhury F; Gaillard S; Wang F; McDonnell DP; Unterman TG; Elam MB; Park EA
J Biol Chem; 2006 Dec; 281(52):39897-906. PubMed ID: 17079227
[TBL] [Abstract][Full Text] [Related]
19. Genetic activation of pyruvate dehydrogenase alters oxidative substrate selection to induce skeletal muscle insulin resistance.
Rahimi Y; Camporez JP; Petersen MC; Pesta D; Perry RJ; Jurczak MJ; Cline GW; Shulman GI
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16508-13. PubMed ID: 25368185
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases.
Sugden MC; Holness MJ
Arch Physiol Biochem; 2006 Jul; 112(3):139-49. PubMed ID: 17132539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
